Earth Science Tech Reports Strong Fiscal Year Results

An announcement from Earth Science Tech ( (ETST) ) is now available.

Earth Science Tech, Inc. reported its financial results for the fiscal year ending March 31, 2025, showcasing significant growth with revenue exceeding $33.1 million and a net profit of $3.2 million. The company achieved a 177.05% increase in revenue and a 300.63% rise in net profit compared to the previous year. The results reflect a strong year-over-year improvement in cash, total assets, and gross profit, indicating robust operational performance and strategic growth. Additionally, the company reduced its outstanding shares by 4.72%, enhancing shareholder value.

Spark’s Take on ETST Stock

According to Spark, TipRanks’ AI Analyst, ETST is a Neutral.

Earth Science Tech exhibits strong financial performance with substantial revenue growth and high returns on equity, bolstered by effective cost management and cash flow generation. Technically, the stock shows moderate momentum, but key averages suggest caution. Valuation is fair, with potential for growth reinvestment, though the absence of a dividend limits appeal to income investors. These factors collectively support a positive, albeit cautious, outlook for the stock.

To see Spark’s full report on ETST stock, click here.

More about Earth Science Tech

Earth Science Tech, Inc. operates as a strategic holding company focused on value creation through the acquisition, operational optimization, and management of its operating businesses. The company is involved in compounding pharmaceuticals, telemedicine, and real estate development through its subsidiaries, including RxCompoundStore.com, Mister Meds, Peaks Curative, Las Villas Health Care, and Avenvi. It also holds an 80% interest in MagneChef and has a charitable arm, Earth Science Foundation, Inc.

Average Trading Volume: 50,779

Technical Sentiment Signal: Buy

Current Market Cap: $44.61M

See more data about ETST stock on TipRanks’ Stock Analysis page.